Island secures API; shortens timeline to ISLA-101 clinical trials
Australian mid-clinical stage antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA) announces that it has entered...
top of page
Search
May 18, 2021
Grupo Renovatio signed the second PPA of its Renewable Auction with ABO Wind
Grupo Renovatio signed the second PPA of its Renewable Auction with ABO Wind. The Renovatio Group and ABO Wind, a company listed on the...
May 17, 2021
Patent Awarded
Island Pharmaceuticals had been awarded a key patent in the United States for ISLA-101, its key asset in the development for antiviral...
Apr 25, 2021
Renovatio Trading Americas Signs PPA Agreement With MPC
Renovatio Trading Americas, a leading Colombian Energy trading firm, has signed a PPA related to the Parque Solar Los Girasoles PV...
Apr 13, 2021
Sucessful IPO
April 13th, 2021 Island Pharmaceuticals had a highly successful IPO on the 13th of April, 2021 raising 7.5 Million AUS. From the...
bottom of page